RhCG Activators
RhCG Activators encompass a diverse range of chemical compounds that indirectly promote the functional activity of RhCG through various signaling pathways, primarily related to ion transport and cellular homeostasis. Forskolin, by raising cAMP levels, could activate PKA, leading to phosphorylation events that enhance RhCG's role in ion transport. Similarly, Genistein, by inhibiting tyrosine kinases, may reduce competitive phosphorylation, thus facilitating pathways that increase RhCG's activity in ammonia transport. Sphingosine-1-phosphate and Thapsigargin both act through lipid and calcium signaling modulation, respectively, which could potentiate RhCG's function in maintaining ion balance. PMA, as a potent PKC activator, and PI3K inhibitors like LY294002 and Wortmannin, may influence RhCG function by altering phosphorylation patterns and membrane dynamics. Inhibitors of MAPK signaling, such as SB203580 and U0126, may also tilt the balance of cellular signaling in favor of enhancing RhCG-mediated ion transport.
Furthermore, compounds like A23187 (Calcimycin), which increases intracellular calcium, could activate calcium-dependent pathways crucial for RhCG's role in ion exchange. Staurosporine, despite its broad-spectrum kinase inhibition, might selectively augment RhCG-related pathways by modifying the activity of kinases that regulate ion transport processes. Lastly, Epigallocatechin gallate (EGCG), known for its kinase inhibitory properties, could modulate signaling pathways, potentially enhancing RhCG's involvement in cellular ion homeostasis. Collectively, these activators, through their targeted effects on cellular signaling, facilitate the enhancement of RhCG-mediated functions, particularly regarding ammonia transport and pH regulation, without the need for upregulating its expression or direct activation.
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Activates adenylyl cyclase, increasing cAMP levels, which in turn could enhance RhCG activity by promoting cAMP-dependent protein kinase A (PKA) signaling, thus affecting ion transport processes associated with RhCG. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Inhibits tyrosine kinases, which may reduce competitive phosphorylation events, thereby potentially enhancing signaling pathways that promote RhCG's role in ammonia transport. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
Acts on sphingosine-1-phosphate receptors, potentially enhancing RhCG activity by modulating membrane lipid organization and signaling, influencing ion transport mechanisms. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Inhibits the sarcoplasmic/endoplasmic reticulum Ca2+ ATPase (SERCA), causing a rise in cytosolic calcium, which could activate calcium-dependent proteins that indirectly increase RhCG activity related to ion homeostasis. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Activates protein kinase C (PKC), which may enhance RhCG activity by phosphorylation of proteins that regulate ion transport and membrane potential, indirectly affecting RhCG function. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
Inhibits phosphatidylinositol 3-kinase (PI3K), potentially altering cell signaling in a way that indirectly enhances RhCG's ammonia transport activity by modifying membrane dynamics. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Another PI3K inhibitor that could indirectly enhance RhCG activity by affecting cell signaling and membrane trafficking, potentially influencing RhCG's role in ammonia transport and pH regulation. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
Inhibits p38 MAP kinase, potentially shifting signaling to favor pathways that enhance RhCG's function in ion transport by altering the cellular stress response. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
Ionophore that increases intracellular calcium, potentially enhancing RhCG activity by activating calcium-dependent signaling pathways that regulate ion transport mechanisms. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
A broad-spectrum protein kinase inhibitor that may lead to the selective enhancement of RhCG pathways by altering kinase activity related to membrane potential and ion transport. | ||||||